Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nvidia Corp (NVDA) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Nvidia CorpTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Nvidia Corp vs uniQure N.V. Ordinary Shares — how do they compare? Nvidia Corp trades at $217.84 (market cap $5.52T), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Nvidia Corp is far larger — about 3729.7× uniQure N.V. Ordinary Shares's market cap, and Nvidia Corp pays a 0.44% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nvidia Corp for 116 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

NVDAQURE
Market Cap
$5.52T$1.48B
Volume
84,036,9412,488,780
Sector
TechnologyHealth
52-Week High
$239.27$70.59
52-Week Low
$165.17$9.03
Typical Hold Time
116 Days0 Days
Enterprise Value
$5.49T$728.62M
Dividend Yield
0.44%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nvidia Corp

NVIDIA (NVDA) trades at $228.52, up 0.97% with strong fundamental performance including 55.84% net profit margin and consistent earnings beats. The stock shows bullish technical signals with support at $225 and resistance at $228. Revenue growth accelerated to $130.5B in 2025, while analyst consensus remains strongly bullish with a $339.17 price target representing 48% upside potential.

NVIDIA's AI leadership and expanding market position support continued growth, though valuation multiples remain elevated. Key risks include increased competition and potential market saturation in AI chips. The company's strong cash flow generation and institutional support provide fundamental backing for long-term investors despite near-term volatility concerns.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVDA
74% Buy26% Sell
Avg holding period · 116 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

Read more on NVDA →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →